logo to the Credentialing Information System  
logo to the  State Medical Asset Resource Tracking Tool
Link to the online tools and services page


West Virginia Office of
Emergency Medical Services

350 Capitol Street
Room 425
Charleston WV, 25301

Toll Free: 1-888--747-8367
OEMS Phone: (304) 558-3956
OEMS Fax: (304) 558-8379
Trauma Phone: (304) 558-7124
Trauma Fax: (304) 558-7125

Hydromorphone Hydrochloride Injection Recall

While the information contained in this news article was current and accurate when we posted it, it may not necessarily represent current WVOEMS policy or procedure. If you have any questions, please contact our office at 304-558-3956.

Posted: Wednesday, May 16, 2012 1:26 PM

On May 12, 2012, Hospira, Inc. announced it is initiating a voluntary user level recall of one lot of Hydromorphone Injection, USP, 1 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject™, NDC 0409-1283-31, due to two reported complaints of a single Carpuject containing more than the 1 mL labeled fill volume.

Opioid pain medications such as Hydromorphone have life-threatening consequences if overdosed. Those consequences can include respiratory depression (slowed breathing or suspension of breathing), low blood pressure and reduced heart rate including circulatory collapse.

The affected product is a prefilled glass cartridge for use with the Carpuject Syringe system.

The affected lot number is 07547LL.

The expiration date is July 1, 2013.

The affected lot was distributed in September - October 2011. It was initially distributed to wholesalers and a limited number of hospitals in Alaska, Alabama, Arizona, California, Colorado, Connecticut, District of Columbia, Delaware, Florida, Indiana, Louisiana, Maryland, Massachusetts, Minnesota, Missouri, Mississippi, North Carolina, New Hampshire, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Washington, and Wisconsin.

Hospira is undertaking this recall in consideration of the potential for safety issues if the product is administered to patients

For More information, please see the FDA's Press Release concerning the recall.

Privacy, Security and Accessibility | WV.gov | USA.gov | © 2013 State of West Virginia | webmail